You just read:

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

News provided by

Sino Medical Sciences Technology Inc. (SINOMED)

Jul 23, 2019, 03:00 ET